Characterization of the Activities of Vorinostat Against Toxoplasma gondii
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020795 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ting Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Hauptthemen laut MEDLINE: Toxoplasma, Vorinostat, Toxoplasmosis, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Medicine and Health Science and Technology Development Plan of Shandong Province, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Toxoplasma gondii is a globally widespread pathogen of significant veterinary and medical importance, causing abortion or congenital disease in humans and other warm-blooded animals. Nevertheless, the current treatment options are restricted and sometimes result in toxic side effects. Hence, it is essential to discover drugs that demonstrate potent anti-Toxoplasma activity. Herein, we found that vorinostat, a pan-HDAC inhibitor, exhibited an IC50 value of 260.1 nM against the T. gondii RH strain and a selectivity index (SI) > 800 with respect to HFF cells. Vorinostat disrupted the entire lytic cycle of T. gondii in vitro. Proteome analysis indicated that vorinostat remarkably perturbed the protein expression of T. gondii, and proteins involved in “DNA replication” and “membrane” were significantly dysregulated. Furthermore, we found that vorinostat significantly enhanced ROS production and induced parasite apoptosis. Importantly, vorinostat could prolong survival in a murine model. Our findings reveal that vorinostat is effective against T. gondii both in vitro and in vivo, suggesting its potential as a therapeutic option for human toxoplasmosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- Shandong Public Health Clinical Center, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
ORCID-Profile: Bing Han, Huai-Yu Zhou
Förderung
- National Natural Science Foundation of China
- Project of Medicine and Health Science and Technology Development Plan of Shandong Province
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Zeng, T., Zhou, C. X., Liu, D. A., Zhao, X. Y., An, X. D., Liu, Z. R., Qu, H. N., Han, B., & Zhou, H. Y. (2025). Characterization of the Activities of Vorinostat Against Toxoplasma gondii. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020795
Vancouver
Zeng T, Zhou CX, Liu DA, Zhao XY, An XD, Liu ZR, et al. Characterization of the Activities of Vorinostat Against Toxoplasma gondii. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020795
BibTeX
@article{Zeng2025,
author = {Zeng, Ting and Zhou, Chun-Xue and Liu, Dai-Ang and Zhao, Xiao-Yan and An, Xu-Dian and Liu, Zhi-Rong and Qu, Hong-Nan and Han, Bing and Zhou, Huai-Yu},
title = {Characterization of the Activities of Vorinostat Against Toxoplasma gondii},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020795}
}
EUVIMED